Multiple roles of the cell cycle inhibitor p21CDKN1A in the DNA damage response

Mutation Research - Reviews in Mutation Research

Volumn 704, Issue 1-3, 2010, Pages 12-20

  Cazzalini, Ornella ^a   Scovassi, A Ivana ^b   Savio, Monica ^a   Stivala, Lucia A ^a   Prosperi, Ennio ^a,b  

^a UNIVERSITY OF PAVIA   (Italy)

^b CNR   (Italy)

Author keywords

Cell cycle checkpoints; DNA damage response; DNA repair; p21CDKN1A; PCNA interaction

Indexed keywords

CCAAT BINDING FACTOR; CYCLIN DEPENDENT KINASE ACTIVATING KINASE; CYCLIN DEPENDENT KINASE INHIBITOR 1A; TRANSCRIPTION FACTOR E2F;

ACETYLATION; APOPTOSIS; AUTOPHAGY; BINDING AFFINITY; BINDING SITE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL CYCLE S PHASE; DNA DAMAGE; DNA REPAIR; DNA REPLICATION; DNA SYNTHESIS; DOWN REGULATION; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HUMAN; MOLECULAR DYNAMICS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; REVIEW; TRANSCRIPTION REGULATION;

APOPTOSIS; CELL CYCLE; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA DAMAGE; DNA REPAIR; GENE EXPRESSION REGULATION; HUMANS; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTEIN PROCESSING, POST-TRANSLATIONAL; TIME;

EID: 77951978240     PISSN: 13835742     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrrev.2010.01.009     Document Type: Review

References (161)

1. Bartek J., and Lukas J. DNA damage checkpoints: from initiation to recovery or adaptation. Curr. Opin. Cell Biol. 19 (2007) 238-245
2. Dotto G.P. p21(WAF1/Cip1): more than a break to the cell cycle?. Biochim. Biophys. Acta 1471 (2000) M43-56
3. Coqueret O. New roles for p21 and p27 cell-cycle inhibitors: a function for each cell compartment?. Trends Cell. Biol. 13 (2003) 65-70
4. Sherr C.J., and Roberts J.M. CDK inhibitors: positive and negative regulators of G1 phase progression. Genes Dev. 13 (1999) 1501-1512
5. Besson A., Dowdy S.F., and Roberts J.M. CDK inhibitors: cell cycle regulators and beyond. Dev. Cell 14 (2008) 159-169
6. Harper J.W., Adami G., Wei N., Keyomarsi K., and Elledge S. The p21 cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75 (1993) 805-816
7. el-Deiry W., Tokino T., Velculescu V.E., Levy D.B., Parsons R., Trent J.M., Lin D., Mercer W.E., Kinzier K.W., and Volgestein B. WAF1, a potential mediator of p53 tumor suppressor. Cell 75 (1993) 817-825
8. Noda A., Ning Y., Venalle S.F., Pereira-Smith O.M., and Smith J.R. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp. Cell Res. 211 (1994) 90-98
9. Chen J., Jackson P.K., Kirschner M.W., and Dutta A. Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA. Nature 374 (1995) 386-388
10. Cip1 cyclin-dependent kinase inhibitor. Oncogene 10 (1995) 2281-2287
11. Cip1. Mol. Cell. Biol. 16 (1996) 4673-4682
12. Fotedar R., Fitzgerald P., Rousselle T., Cannella D., Dorée M., Messier H., and Fotedar A. p21 contains independent binding sites for cyclin and cdk2: both sites are required to inhibit cdk2 kinase activity. Oncogene 12 (1996) 2155-2164
13. Flores-Rozas H., Kelman Z., Dean F.B., Pan Z.Q., Harper J.W., Elledge S.J., O'Donnell M., and Hurwitz J. Cdk-interacting protein 1 directly binds with proliferating cell nuclear antigen and inhibits DNA replication catalyzed by the DNA polymerase delta holoenzyme. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 8655-8659
14. Waga S., Hannon G.J., Beach D., and Stillman B. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 369 (1994) 574-578
15. Luo Y., Hurwitz J., and Massagué J. Cell-cycle inhibition by independent CDK and PCNA binding domains in p21. Nature 375 (1995) 159-161
16. Cip1/Waf1 peptide domains required for cyclin E/cdk2 and PCNA interactions. Oncogene 12 (1996) 595-607
17. Prosperi E. The fellowship of the rings: distinct pools of proliferating cell nuclear antigen (PCNA) trimer at work. FASEB J. 20 (2006) 833-837
18. Moldovan G.L., Pfander B., and Jentsch S. PCNA, the maestro of replication fork. Cell 129 (2007) 665-679
19. Cip1 is a determinant for target protein recognition. ChemBioChem. 4 (2003) 863-869
20. Child E.S., and Mann D.J. The intricacies of p21 phosphorylation: protein/protein interactions, subcellular localization and stability. Cell Cycle 12 (2006) 1313-1319
21. Waldman T., Kinzler K.W., and Vogelstein B. p21 is necessary for the p53-mediated G1 arrest in human cancer cells. Cancer Res. 55 (1995) 5187-5190
22. Brugarolas J., Moberg K., Boyd S.D., Taya Y., Jacks T., and Lees J.A. Inhibition of cyclin-dependent kinase 2 by p21 is necessary for retinoblastoma protein-mediated G1 arrest after gamma-irradiation. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 1002-1007
23. Ewen M.E., Sluss H.K., Sherr C.J., Matsushime H., Kato J., and Livingston D.M. Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell 73 (1993) 487-497
24. el-Deiry W.S., Harper J.W., O'Connor P.M., Velculescu V.E., Canman C.E., Jackman J., Pietenpol J.A., Burrell M., Hill D.E., Wang Y., Wiman K.G., Mercer W.E., Kastan M.B., Kohn K.W., Elledge S.J., Kinzler K.W., and Vogelstein B. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res. 54 (1994) 1169-1174
25. CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82 (1995) 675-684
26. Brugarolas J., Chandrasekaran C., Gordon J.I., Beach D., Jacks I., and Hannon G.J. Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature 377 (1995) 552-557
27. Satyanarayana A., Hilton M.B., and Kaldis P. p21 inhibits CDK1 in the absence of Cdk2 to maintain the G1/S phase DNA damage checkpoint. Mol. Biol. Cell 19 (2008) 65-77
28. Gulbis J.M., Kelman Z., Hurtwitz J., O'Donnel M., and Kuriyan J. Structure of the C-terminal region of p21waf1/cip1 complexed with human PCNA. Cell 87 (1996) 297-306
29. Oku T., Ikeda S., Sasaki H., Fukuda K., Morioka H., Ohtsuka E., Yoshikawa H., and Tsurimoto T. Functional sites of human PCNA which interact with p21 (Cip1/Waf1), DNA polymerase delta and replication factor C. Gene Cells 3 (1998) 357-369
30. Warbrick E., Lane D.P., Glover D.M., and Cox L.S. A small peptide inhibitor of DNA replication defines the site of interaction between the cyclin-dependent kinase inhibitor p21WAF1 and proliferating cell nuclear antigen. Curr. Biol. 5 (1995) 275-282
31. Chen J., Peters R., Saha P., Lee P., Theodoras A., Pagano M., Wagner G., and Dutta A. A 39 amino acid fragment of the cell cycle regulator p21 is sufficient to bind PCNA and partially inhibit DNA replication in vivo. Nucleic Acids Res. 24 (1996) 1727-1733
32. Cayrol C., Knibiehler M., and Ducommun B. p21 binding to PCNA causes G1 and G2 cell cycle arrest in p53-deficient cells. Oncogene 16 (1998) 311-320
33. Rousseau D., Cannella D., Boulaire J., Fitzgerald P., Fotedar A., and Fotedar R. Growth inhibition by CDK-cyclin and PCNA binding domains of p21 occurs by distinct mechanisms and is regulated by ubiquitin-proteasome pathway. Oncogene 18 (1999) 4313-4325
34. Mattock H., Lane D.P., and Warbrick E. Inhibition of cell proliferation by the PCNA-binding protein region of p21 expressed as a GFP miniprotein. Exp. Cell Res. 265 (2001) 234-241
35. CDKN1A does not interfere with loading of PCNA at DNA replication sites, but inhibits subsequent binding of DNA polymerase δ at the G1/S phase transition. Cell Cycle 2 (2003) 596-603
36. Cip1 in S phase. J. Biol. Chem. 278 (2003) 25752-25757
37. Gottifredi V., McKinney K., Poyurovsky M.V., and Prives C. Decreased p21 levels are required for efficient restart of DNA synthesis after S phase block. J. Biol. Chem. 279 (2004) 5802-5810
38. Li H., Xie B., Rahmeh A., Zhou Y., and Lee M.Y.W.T. Direct interaction of p21 with p50, the small subunit of human DNA polymerase delta. Cell Cycle 5 (2006) 428-436
39. cip1/waf1-dependent DNA-damage checkpoint signals contributes to cell cycle arrest at G1/S transition. Genes Cells 9 (2004) 131-142
40. Bunz F., Dutriaux A., Lengauer C., Waldman T., Zhou S., Brown J.P., Sedivy J.M., Kinzler K.W., and Vogelstein B. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 282 (1998) 1497-1501
41. Cip1/Waf1 at both the G1/S and the G2/M cell cycle transitions: pRb is a critical determinant in blocking DNA replication and in preventing endoreduplication. Mol. Cell. Biol. 18 (1998) 629-643
42. Waldman T., Lengauer C., Kinzler K.W., and Vogelstein B. Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21. Nature 381 (1996) 713-716
43. Harper J.W., Elledge S.J., Keyomarsi K., Dynlacht B., Tsai L.H., Zhang P., Dobrowolski S., Bai C., Connell-Crowley L., Swindell E., Fox M.P., and Wei N. Inhibition of cyclin-dependent kinases by p21. Mol. Biol. Cell 6 (1995) 387-400
44. Smits V.A., Klompmaker R., Vallenius T., Rijksen G., Mäkela T.P., and Medema R.H. p21 inhibits Thr161 phosphorylation of Cdc2 to enforce the G2 DNA damage checkpoint. J. Biol. Chem. 275 (2000) 30638-30643
45. Cip1 at the onset of mitosis: a role at the G2/M-phase transition. Mol. Cell. Biol. 18 (1998) 546-557
46. Baus F., Gire V., Fisher D., Piette J., and Dulić V. Permanent cell cycle exit in G2 phase after DNA damage in normal human fibroblasts. EMBO J. 22 (2003) 3992-4002
47. Charrier-Savournin F.B., Château M.T., Gire V., Sedivy J., Piette J., and Dulic V. p21-Mediated nuclear retention of cyclin B1-Cdk1 in response to genotoxic stress. Mol. Biol. Cell 15 (2004) 3965-3976
48. waf1/cip1 mediates cyclin B1 degradation in response to DNA damage. Cell Cycle 8 (2009) 253-256
49. Lee J., Kim A.K., Barbier V., Fotedar A., and Fotedar R. DNA damage triggers p21WAF1-dependent Emi1 down-regulation that maintains G2 arrest. Mol. Biol. Cell 20 (2009) 1891-1902
50. Liu S., Bishop W.R., and Liu M. Differential effects of cell cycle regulatory protein p21(WAF1/Cip1) on apoptosis and sensitivity to cancer chemotherapy. Drug Resist. Update 6 (2003) 183-195
51. Blundell R.A. The biology of p21Waf1\Cip1. Am. J. Biochem. Biotechnol. 2 (2006) 33-40
52. Garner E., and Raj K. Protective mechanisms of p53-p21-pRb proteins against DNA damage-induced cell death. Cell Cycle 7 (2008) 277-282
53. Abbas T., and Dutta A. p21 in cancer: intricate networks and multiple activities. Nat. Rev. Cancer 9 (2009) 400-414
54. Waldman T., Zhang Y., Dillehay L., Yu J., Kinzler K., Vogelstein B., and Williams J. Cell-cycle arrest versus cell death in cancer therapy. Nat. Med. 3 (1997) 1034-1036
55. Suzuki A., Tsutomi Y., Akahane K., Araki T., and Miura M. Resistance to Fas-mediated apoptosis: activation of caspase 3 is regulated by cell cycle regulator p21WAF1 and IAP gene family ILP. Oncogene 17 (1998) 931-939
56. Suzuki A., Tsutomi Y., Miura M., and Akahane K. Caspase 3 inactivation to suppress Fas-mediated apoptosis: identification of binding domain with p21 and ILP and inactivation machinery by p21. Oncogene 18 (1999) 1239-1244
57. Baptiste-Okoh N., Barsotti A.M., and Prives C. Caspase 2 is both required for p53-mediated apoptosis and downregulated by p53 in a p21-dependent manner. Cell Cycle 7 (2008) 1133-1138
58. Gervais J.L., Seth P., and Zhang H. Cleavage of CDK inhibitor p21(Cip1/Waf1) by caspases is an early event during DNA damage-induced apoptosis. J. Biol. Chem. 273 (1998) 19207-19212
59. Levkau B., Koyama H., Raines E.W., Clurman B.E., Herren B., Orth K., Roberts J.M., and Ross R. Cleavage of p21Cip1/Waf1 and p27Kip1 mediates apoptosis in endothelial cells through activation of Cdk2: role of a caspase cascade. Mol. Cell 1 (1998) 553-563
60. Jin Y.H., Yoo K.J., Lee Y.H., and Lee S.K. Caspase 3-mediated cleavage of p21WAF1/CIP1 associated with the cyclin A-cyclin-dependent kinase 2 complex is a prerequisite for apoptosis in SK-HEP-1 cells. J. Biol. Chem. 275 (2000) 30256-30263
61. Asada M., Yamada T., Ichijo H., Delia D., Miyazono K., Fukumuro K., and Mizutani S. Apoptosis inhibitory activity of cytoplasmic p21(Cip1/WAF1) in monocytic differentiation. EMBO J. 18 (1999) 1223-1234
62. Huang S., Shu L., Dilling M.B., Easton J., Harwood F.C., Ichijo H., and Houghton P.J. Sustained activation of the JNK cascade and rapamycin-induced apoptosis are suppressed by p53/p21(Cip1). Mol. Cell 11 (2003) 1491-1501
63. Xue Y., Ramaswamy N.T., Hong X., and Pelling J.C. Association of JNK1 with p21waf1 and p53: modulation of JNK1 activity. Mol. Carcinog. 36 (2003) 38-44
64. Zhan J., Easton J.B., Huang S., Mishra A., Xiao L., Lacy E.R., Kriwacki R.W., and Houghton P.J. Negative regulation of ASK1 by p21Cip1 involves a small domain that includes Serine 98 that is phosphorylated by ASK1 in vivo. Mol. Cell. Biol. 27 (2007) 3530-3541
65. Le H.V., Minn A.J., and Massagué J. Cyclin-dependent kinase inhibitors uncouple cell cycle progression from mitochondrial apoptotic functions in DNA-damaged cancer cells. J. Biol. Chem. 280 (2005) 32018-32025
66. Sohn D., Essmann F., Schulze-Osthoff K., and Jänicke R.U. p21 blocks irradiation-induced apoptosis downstream of mitochondria by inhibition of cyclin-dependent kinase-mediated caspase-9 activation. Cancer Res. 66 (2006) 11254-11262
67. Jänicke R.U., Essmann F., and Schulze-Osthoff K. The multiple battles fought by anti-apoptotic p21. Cell Cycle 6 (2007) 407-413
68. Fan Y., Borowsky A.D., and Weiss R.H. An antisense oligodeoxynucleotide to p21(Waf1/Cip1) causes apoptosis in human breast cancer cells. Mol. Cancer Ther. 2 (2003) 773-782
69. Weiss R.H. p21Waf1/Cip1 as a therapeutic target in breast and other cancers. Cancer Cell 4 (2003) 425-429
70. Weiss R.H., Marshall D., Howard L., Corbacho A.M., Cheung A.T., and Sawai E.T. Suppression of breast cancer growth and angiogenesis by an antisense oligodeoxynucleotide to p21(Waf1/Cip1). Cancer Lett. 189 (2003) 39-48
71. Park S.H., Park J.Y., and Weiss R.H. Antisense attenuation of p21 sensitizes kidney cancer to apoptosis in response to conventional DNA damaging chemotherapy associated with enhancement of phospho-p53. J. Urol. 180 (2008) 352-360
72. Lin P.Y., Fosmire S.P., Park S.H., Park J.Y., Baksh S., Modiano J.F., and Weiss R.H. Attenuation of PTEN increases p21 stability and cytosolic localization in kidney cancer cells: a potential mechanism of apoptosis resistance. Mol. Cancer 14 (2007) 6-16
73. Seoane J., Le H.V., and Massagué J. Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage. Nature 419 (2002) 729-734
74. Tian H., Wittmack E.K., and Jorgensen T.J. p21WAF1/CIP1 antisense therapy radiosensitizes human colon cancer by converting growth arrest to apoptosis. Cancer Res. 60 (2000) 679-684
75. CIP1/WAF1 in apoptosis. Leuk. Res. 29 (2005) 1237-1238
76. Fotedar R., Brickner H., Saadatmandi N., Rousselle T., Diederich L., Munshi A., Jung B., Reed J.C., and Fotedar A. Effect of p21waf1/cip1 transgene on radiation induced apoptosis in T cells. Oncogene 18 (1999) 3652-3658
77. Chopin V., Toillon R.A., Jouy N., and Le Bourhis X. P21(WAF1/CIP1) is dispensable for G1 arrest, but indispensable for apoptosis induced by sodium butyrate in MCF-7 breast cancer cells. Oncogene 23 (2004) 21-29
78. Kraljevic Pavelic S., Cacev T., and Kralj M. A dual role of p21waf1/cip1 gene in apoptosis of HEp-2 treated with cisplatin or methotrexate. Cancer Gene Ther. 15 (2008) 576-590
79. Blagosklonny M.V. Are p27 and p21 cytoplasmic oncoproteins?. Cell Cycle 1 (2002) 391-393
80. Savio M., Coppa T., Cazzalini O., Perucca P., Necchi D., Nardo T., Stivala L.A., and Prosperi E. Degradation of p21CDKN1A after DNA damage is independent of type of lesion, and is not required for DNA repair. DNA Repair 8 (2009) 778-785
81. Martinez L.A., Yang J., Vazquez E.S., Rodriguez-Vargas M.del.C., Olive M., Hsieh J.T., Logothetis C.J., and Navone N.M. p21 modulates threshold of apoptosis induced by DNA-damage and growth factor withdrawal in prostate cancer cells. Carcinogenesis 23 (2002) 1289-1296
82. Lee E.W., Lee M.S., Camus S., Ghim J., Yang M.R., Oh W., Ha N.C., Lane D.P., and Song J. Differential regulation of p53 and p21 by MKRN1 E3 ligase controls cell cycle arrest and apoptosis. EMBO J. 28 (2009) 2100-2113
83. Eisenberg-Lerner A., Bialik S., Simon U.K., and Kimchi A. Life and death partners: apoptosis, autophagy and the cross-talk between them. Cell Death Differ. 16 (2009) 966-975
84. Fujiwara K., Daido S., Yamamoto A., Kobayashi R., Yokoyama T., Aoki H., Iwado E., Shinojima N., Kondo Y., and Kondo S. Pivotal role of the cyclin-dependent kinase inhibitor p21WAF1/CIP1 in apoptosis and autophagy. J. Biol. Chem. 283 (2008) 388-397
85. Zhang G., Park M.A., Mitchell C., Walker T., Hamed H., Studer E., Graf M., Rahmani M., Gupta S., Hylemon P.B., Fisher P.B., Grant S., and Dent P. Multiple cyclin kinase inhibitors promote bile acid-induced apoptosis and autophagy in primary hepatocytes via p53-CD95-dependent signaling. J. Biol. Chem. 283 (2008) 24343-24358
86. Green D.R., and Kroemer G. Cytoplasmic functions of the tumour suppressor p53. Nature 458 (2009) 1127-1130
87. Maiuri M.C., Tasdemir E., Criollo A., Morselli E., Vicencio J.M., Carnuccio R., and Kroemer G. Control of autophagy by oncogenes and tumor suppressor genes. Cell Death Differ. 16 (2009) 87-93
88. (WAF1/CIP1/SDI1). Cell Cycle 1 (2002) 39-41
89. Fritah A., Saucier C., Mester J., Redeuilh G., and Sabbah M. p21WAF1/CIP1 selectively controls the transcriptional activity of estrogen receptor alpha. Mol. Cell. Biol. 25 (2005) 2419-2430
90. Broude E.V., Demidenko Z.N., Vivo C., Swift M.E., Davis B.M., Blagosklonny M.V., and Roninson I.B. p21 (CDKN1A) is a negative regulator of p53 stability. Cell Cycle 6 (2007) 1468-1471
91. WAF1/CIP1/SDI1. J. Biol. Chem. 275 (2000) 18794-18800
92. Shiyanov P., Bagchi S., Adami G., Kokontis J., Hay N., Arroyo M., Morozov A., and Raychaudhuri P. p21 disrupts the interaction between cdk2 and the E2F-p130 complex. Mol. Cell. Biol. 16 (1996) 737-744
93. Delavaine L., and La Thangue N.B. Control of E2F activity by p21Waf1/Cip1. Oncogene 18 (1999) 5381-5392
94. Kitaura H., Shinshi M., Uchikoshi Y., Ono T., Iguchi-Ariga S.M., and Ariga H. Reciprocal regulation via protein-protein interaction between c-Myc and p21(cip1/waf1/sdi1) in DNA replication and transcription. J. Biol. Chem. 275 (2000) 10477-10483
95. Zhu H., Chang B.D., Uchiumi T., and Roninson I.B. Identification of promoter elements responsible for transcriptional inhibition of polo-like kinase 1 and topoisomerase II alpha genes by p21(WAF1/CIP1/SDI1). Cell Cycle 1 (2002) 59-66
96. Cip1/WAF1 transcriptional target conferring resistance of keratinocytes to UV light-induced apoptosis. J. Biol. Chem. 280 (2005) 37725-37731
97. waf1 binds to the myc and cdc25A promoters upon DNA damage and induces transcriptional repression. J. Biol. Chem. 281 (2006) 34742-34750
98. Perkins N.D., Felzien L.K., Betts J.C., Leung K., Beach D.H., and Nabel G.J. Regulation of NF-kappaB by cyclin-dependent kinases associated with the p300 coactivator. Science 275 (1997) 523-527
99. Redeuilh G., Attia A., Mester J., and Sabbah M. Transcriptional activation by the oestrogen receptor alpha is modulated through inhibition of cyclin-dependent kinases. Oncogene 21 (2002) 5773-5782
100. Brouillard F., and Cremisi C.E. Concomitant increase of histone acetyltransferase activity and degradation of p300 during retinoic acid-induced differentiation of F9 cells. J. Biol. Chem. 278 (2003) 39509-39516
101. Polesskaya A., Naguibneva I., Fritsch L., Duquet A., Ait-Si-Ali S., Robin P., Vervisch A., Pritchard L.L., Cole P., and Harel-Bellan A. CBP/p300 and muscle differentiation: no HAT, no muscle. EMBO J. 20 (2001) 6816-6825
102. Datto M.B., Hu P.P., Kowalik T.F., Yingling J., and Wang X.F. The viral oncoprotein E1A blocks transforming growth factor beta-mediated induction of p21/WAF1/Cip1 and p15/INK4B. Mol. Cell. Biol. 17 (1997) 2030-2037
103. Missero C., Calautti E., Eckner R., Chin J., Tsai L.H., Livingston D.M., and Dotto G.P. Involvement of the cell-cycle inhibitor Cip1/WAF1 and the E1A-associated p300 protein in terminal differentiation. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 5451-5455
104. Martinez-Balbás M.A., Bannister A.J., Martin K., Haus-Seuffert P., Meisterernst M., and Kouzarides T. The acetyltransferase activity of CBP stimulates transcription. EMBO J. 17 (1998) 2886-2893
105. Nakajima T., Uchida C., Anderson S.F., Lee C.G., Hurwitz J., Parvin J.D., and Montminy M. RNA helicase A mediates association of CBP with RNA polymerase II. Cell 90 (1997) 1107-1112
106. Devgan V., Mammucari C., Millar S.E., Brisken C., and Dotto G.P. p21WAF1/Cip1 is a negative transcriptional regulator of Wnt4 expression downstream of Notch1 activation. Genes Dev. 19 (2005) 1485-1495
107. Gregory D.J., Garcia-Wilson E., Poole J.C., Snowden A.W., Roninson I.B., and Perkins N.D. Induction of transcription through the CRD1 motif by p21WAF1/CIP1 is core promoter specific and cyclin dependent kinase independent. Cell Cycle 1 (2002) 343-350
108. Tan H.H., and Porter A.G. p21(WAF1) negatively regulates DNMT1 expression in mammalian cells. Biochem. Biophys. Res. Commun. 382 (2009) 171-176
109. Cazzalini O., Perucca P., Savio M., Necchi D., Bianchi L., Stivala L.A., Ducommun B., Scovassi A.I., and Prosperi E. Interaction of p21(CDKN1A) with PCNA regulates the histone acetyltransferase activity of p300 in nucleotide excision repair. Nucleic Acids Res. 36 (2008) 1713-1722
110. Rubbi C.P., and Milner J. p53 is a chromatin accessibility factor for nucleotide excision repair of DNA damage. EMBO J. 22 (2003) 975-986
111. Hong R., and Chakravarti D. The human proliferating cell nuclear antigen regulates transcriptional coactivator p300 activity and promotes transcriptional repression. J. Biol. Chem. 278 (2003) 44505-44513
112. Chang B.D., Watanabe K., Broude E.V., Fang J., Poole J.C., Kalinichenko T.V., and Roninson I.B. Effects of p21Waf1/Cip1/Sdi1 on cellular gene expression: implications for carcinogenesis, senescence, and age-related diseases. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 4291-4296
113. Poole J.C., Thain A., Perkins N.D., and Roninson I.B. Induction of transcription by p21Waf1/Cip1/Sdi1: role of NFkappaB and effect of non-steroidal anti-inflammatory drugs. Cell Cycle 3 (2004) 931-940
114. Pan Z.-Q., Reardon J.T., Li L., Flores-Rozas H., Legerski R., Sancar A., and Hurwitz J. Inhibition of nucleotide excision repair by cyclin-dependent kinase inhibitor p21. J. Biol. Chem. 270 (1995) 22008-22016
115. Podust V.N., Podust L., Goubin F., Ducommun B., and Hübscher H. Mechanism of inhibition of proliferating cell nuclear antigen-dependent DNA synthesis by the cyclin-dependent kinase inhibitor p21. Biochemistry 34 (1995) 8869-8875
116. Cooper M.P., Balajee A.S., and Bohr V.A. The C-terminal domain of p21 inhibits nucleotide excision repair in vitro and in vivo. Mol. Biol. Cell 10 (1999) 2119-2129
117. Smith L., Ford J.M., Hollander M.C., Bortnick R.A., Amounson S.A., Seo Y.R., Deng C., Hanawalt P.C., and Fornace A.J. p53-mediated DNA repair responses to UV radiation: studies of mouse cells lacking p53, p21, and/or gadd45 genes. Mol. Cell. Biol. 20 (2000) 3705-3714
118. Adimoolam S., Lin C.X., and Ford J.M. The p53 regulated cyclin-dependent kinase inhibitor, p21 (cip1,waf1,sdi1), is not required for global genomic and transcriptional coupled nucleotide excision repair of UV-induced DNA photoproducts. J. Biol. Chem. 28 (2001) 25813-25822
119. Therrien J.P., Loignon M., Drouin R., and Drobetsky E.A. Ablation of p21waf1cip1 expression enhances the capacity of p53-deficient human tumor cells to repair UVB-induced DNA damage. Cancer Res. 61 (2001) 3781-3786
120. waf/cip1 expression exhibit normal nucleotide excision repair of UV-induced DNA damage. Carcinogenesis 3 (2002) 403-410
121. Shivji M.K.K., Grey S.J., Strausfeld U.P., Wood R.D., and Blow J.J. Cip1 inhibits DNA replication but not PCNA-dependent nucleotide excision repair. Curr. Biol. 4 (1994) 1062-1068
122. Shivji M.K.K., Ferrari E., Ball K., Hübscher U., and Wood R.D. Resistance of human nucleotide excision repair synthesis in vitro to p21CDKN1. Oncogene 17 (1998) 2827-2838
123. waf1/cip1-/- human cancer cells. Cancer Res. 56 (1996) 2250-2255
124. Sheikh M.S., Chen Y.Q., Smith M.L., and Fornace Jr. A.J. Role of p21waf/cip1/sdi1 in cell death and DNA repair as studied using a tetracycline-inducible system in p53-deficient cells. Oncogene 14 (1997) 1875-1882
125. Li R., Hannon G.J., Beach D., and Stillman B. Subcellular distribution of p21 and PCNA in normal and repair-deficient cells following DNA damage. Curr. Biol. 6 (1996) 189-199
126. waf1/cip1 protein associates with the detergent-insoluble form of PCNA concomitantly with disassembly of PCNA at nucleotide excision repair sites. Oncogene 13 (1996) 1591-1598
127. Ruan S., Okcu M.F., Ren J.P., Chiao P., Andreeff M., Levin V., and Zhang W. Overexpressed WAF1/Cip1 renders glioblastoma cells resistant to chemotherapy agents 1,3-bis(2-chloroethyl)-1-nitrosourea and cisplatin. Cancer Res. 58 (1998) 1538-1543
128. waf1/cip1-null human fibroblasts are deficient in nucleotide excision repair downstream the recruitment of PCNA to DNA repair sites. Oncogene 20 (2001) 563-570
129. Hanawalt P.C. Revisiting the rodent repairadox. Environ. Mol. Mutagen. 38 (2001) 89-96
130. CDKN1A protein recruitment to DNA-damage sites and interaction with proliferating cell nuclear antigen. J. Cell Sci. 119 (2006) 1517-1527
131. Soria G., Speroni J., Podhajcer O.L., Prives C., and Gottifredi V. p21 differentially regulates DNA replication and DNA-repair-associated processes after UV irradiation. J. Cell Sci. 121 (2008) 3271-3282
132. WAF1/CIP1 protein prior to its cytosolic degradation by UV enhances DNA repair and survival. Biochem. Biophys. Res. Commun. 390 (2009) 1361-1366
133. Mocquet V., Lainé J.P., Riedl T., Yajin Z., Lee M.Y., and Egly J.M. Sequential recruitment of the repair factors during NER: the role of XPG in initiating the resynthesis step. EMBO J. 27 (2007) 155-167
134. Jakob B., Scholz M., and Taucher-Scholz G. Characterization of CDKN1A (p21) binding to sites of heavy-ion-induced damage: colocalization with proteins involved in DNA repair. Int. J. Radiat. Biol. 78 (2002) 75-88
135. Hasan S., Hassa P.O., Imhof R., and Hottiger M.O. Transcription coactivator p300 binds PCNA and may have a role in DNA repair synthesis. Nature 410 (2001) 387-391
136. Avkin S., Sevilya Z., Toube L., Geacintov N., Chaney S.G., Oren M., and Livneh Z. p53 and p21 regulate error-prone DNA repair to yield a lower mutation load. Mol. Cell 22 (2006) 407-413
137. Prives C., and Gottifredi V. The p21 and PCNA partnership. A new twist for an old plot. Cell Cycle 7 (2008) 3840-3846
138. Cip1/WAF1 downregulation is required for efficient PCNA ubiquitination after UV irradiation. Oncogene 25 (2006) 2829-2838
139. Tom S., Ranalli T.A., Podust V.N., and Bambara R.A. Regulatory roles of p21 and apurinic/apyrimidinic endonuclease 1 in base excision repair. J. Biol. Chem. 276 (2001) 48781-48789
140. waf1/cip1. A dynamic exchange of partners. J. Biol. Chem. 278 (2003) 39265-39268
141. WAF1 to promote DNA repair. Cell 114 (2003) 599-610
142. WAF1/CIP1 for proteasomal degradation after UV irradiation. Mol. Cell. Biol. 27 (2007) 3187-3198
143. WAF1/CIP1 expression. Biochem. Biophys. Res. Commun. 227 (1996) 564-569
144. Cip1 ubiquitination. Mol. Cell 5 (2000) 403-410
145. Bloom J., Amador V., Bartolini F., DeMartino G., and Pagano M. Proteasome-mediated degradation of p21 via N-terminal ubiquitinylation. Cell 115 (2003) 71-82
146. Waf1/Cip1 protein stability via cyclin-D1-imposed block in proteasome-mediated degradation. EMBO J. 22 (2003) 2036-2046
147. WAF1/CIP1 is a binding site for the C8 α-subunit of the 20S proteasome. EMBO J. 20 (2001) 2367-2375
148. Zhang Z., Wang H., Li M., Agrawal S., Chen X., and Zhang R. MDM2 is a negative regulator of p21WAF1/CIP1, independent of p53. J. Biol. Chem. 279 (2004) 16000-16006
149. Lee H., Zeng S.X., and Lu H. UV induces p21 rapid turnover independently of ubiquitin and Skp2. J. Biol. Chem. 281 (2006) 26876-26883
150. Cdc20 controls the ubiquitin-mediated degradation of p21 in prometaphase. Mol. Cell 27 (2007) 462-473
151. Cip1 to control replication licensing. Genes Dev. 22 (2008) 2507-2519
152. Cdt2 ubiquitin ligase complex. Genes Dev. 22 (2008) 2496-2506
153. Cdt2 pathway during S phase and after UV irradiation. J. Biol. Chem. 283 (2008) 29045-29052
154. Cip1 in transformed cells. J. Biol. Chem. 284 (2009) 15061-15070
155. Cayrol C., and Ducommun B. Interaction with cyclin-dependent kinases and PCNA modulates proteasome-dependent degradation of p21. Oncogene 17 (1998) 2437-2444
156. Liu L., Lee S., Zhang J., Peters S.B., Hannah J., Zhang Y., Yin Y., Koff A., Ma L., and Zhou P. Cul4A abrogation augments DNA damage response and protection against skin carcinogenesis. Mol. Cell 34 (2009) 451-460
157. waf1 and bax expression: implications for DNA repair, UV sensitivity and the induction of apoptosis. Oncogene 17 (1998) 545-555
158. CDKN1A in cells surviving UV-irradiation. DNA Repair 4 (2005) 1457-1462
159. Stoyanova T., Roy N., Kopanja D., Bagchi S., and Raychaudhuri P. DDB2 decides cell fate following DNA damage. Proc. Natl. Acad. Sci. U.S.A. 106 (2009) 10690-10695
160. Martin-Caballero J., Flores J.M., Garcìa-Palencia P., and Serrano M. Tumour susceptibility of p21waf1/cip1-deficient mice. Cancer Res. 61 (2001) 6234-6238
161. O. Cazzalini, F. Donà, M. Savio, M. Tillhon, C. Maccario, P. Perucca, L.A. Stivala, A.I. Scovassi, E., Prosperi, p21CDKN1A participates in base excision repair by regulating the activity of poly(ADP-ribose) polymerase 1. DNA Repair.